Tags

Type your tag names separated by a space and hit enter

Oligoanovulation with polycystic ovaries but not overt hyperandrogenism.
J Clin Endocrinol Metab 2006; 91(10):3922-7JC

Abstract

OBJECTIVES

By requiring a minimum of two of three items [hyperandrogenism (HA), oligoanovulation (OA), and polycystic ovaries (PCO) at ultrasound], the Rotterdam definition recognizes four PCO syndrome (PCOS) phenotypes: HA+OA+PCO (full-blown syndrome), HA+OA (former National Institutes of Health definition), HA+PCO (ovulatory PCOS), and OA+PCO. However, the latter phenotype is controversial, and it is not known to what extent it shares similarities with the others.

DESIGN

The study was a comparative analysis of hormonal, metabolic, and ultrasound parameters obtained from patients and controls that were consecutively included in a database.

PATIENTS AND METHODS

Sixty-six patients having OA+PCO without hirsutism or elevated serum androstenedione and testosterone levels were compared with 118 normally cycling nonhyperandrogenic age-matched women without PCO (controls). These patients (phenotype D) were also compared with patients with HA+OA+PCO (phenotype A, n = 246), HA+OA (phenotype B, n = 27), and HA+PCO (phenotype C, n = 67).

RESULTS

Patients with phenotype D had higher mean values of waist circumference and higher mean levels of serum testosterone, androstenedione, and LH than controls. Conversely, they had lower mean serum levels of FSH and SHBG (P < 0.05 for each parameter). Variance analysis disclosed significant group effects between the different patients' phenotypes for all parameters, except age, BMI, and FSH. After multiple comparisons with post hoc analysis, phenotype D had milder endocrine and metabolic abnormalities than phenotype A, although it did not differ from phenotype C, except for androgen data, by definition. Phenotypes A and B were statistically similar, except for the ultrasound data, by definition.

CONCLUSION

Oligoanovulatory patients with PCO but without HA have mild endocrine and metabolic features of PCOS.

Authors+Show Affiliations

Department of Endocrine Gynecology and Reproductive Medicine, Hôpital Jeanne de Flandre, Centre Hospitalier Régional Universitaire, 59037 Lille, France. ddewailly@chru-lille.frNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16849400

Citation

Dewailly, Didier, et al. "Oligoanovulation With Polycystic Ovaries but Not Overt Hyperandrogenism." The Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 10, 2006, pp. 3922-7.
Dewailly D, Catteau-Jonard S, Reyss AC, et al. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. J Clin Endocrinol Metab. 2006;91(10):3922-7.
Dewailly, D., Catteau-Jonard, S., Reyss, A. C., Leroy, M., & Pigny, P. (2006). Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. The Journal of Clinical Endocrinology and Metabolism, 91(10), pp. 3922-7.
Dewailly D, et al. Oligoanovulation With Polycystic Ovaries but Not Overt Hyperandrogenism. J Clin Endocrinol Metab. 2006;91(10):3922-7. PubMed PMID: 16849400.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. AU - Dewailly,Didier, AU - Catteau-Jonard,Sophie, AU - Reyss,Anne-Céline, AU - Leroy,Maryse, AU - Pigny,Pascal, Y1 - 2006/07/18/ PY - 2006/7/20/pubmed PY - 2006/11/14/medline PY - 2006/7/20/entrez SP - 3922 EP - 7 JF - The Journal of clinical endocrinology and metabolism JO - J. Clin. Endocrinol. Metab. VL - 91 IS - 10 N2 - OBJECTIVES: By requiring a minimum of two of three items [hyperandrogenism (HA), oligoanovulation (OA), and polycystic ovaries (PCO) at ultrasound], the Rotterdam definition recognizes four PCO syndrome (PCOS) phenotypes: HA+OA+PCO (full-blown syndrome), HA+OA (former National Institutes of Health definition), HA+PCO (ovulatory PCOS), and OA+PCO. However, the latter phenotype is controversial, and it is not known to what extent it shares similarities with the others. DESIGN: The study was a comparative analysis of hormonal, metabolic, and ultrasound parameters obtained from patients and controls that were consecutively included in a database. PATIENTS AND METHODS: Sixty-six patients having OA+PCO without hirsutism or elevated serum androstenedione and testosterone levels were compared with 118 normally cycling nonhyperandrogenic age-matched women without PCO (controls). These patients (phenotype D) were also compared with patients with HA+OA+PCO (phenotype A, n = 246), HA+OA (phenotype B, n = 27), and HA+PCO (phenotype C, n = 67). RESULTS: Patients with phenotype D had higher mean values of waist circumference and higher mean levels of serum testosterone, androstenedione, and LH than controls. Conversely, they had lower mean serum levels of FSH and SHBG (P < 0.05 for each parameter). Variance analysis disclosed significant group effects between the different patients' phenotypes for all parameters, except age, BMI, and FSH. After multiple comparisons with post hoc analysis, phenotype D had milder endocrine and metabolic abnormalities than phenotype A, although it did not differ from phenotype C, except for androgen data, by definition. Phenotypes A and B were statistically similar, except for the ultrasound data, by definition. CONCLUSION: Oligoanovulatory patients with PCO but without HA have mild endocrine and metabolic features of PCOS. SN - 0021-972X UR - https://www.unboundmedicine.com/medline/citation/16849400/Oligoanovulation_with_polycystic_ovaries_but_not_overt_hyperandrogenism L2 - https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2006-1054 DB - PRIME DP - Unbound Medicine ER -